High‐Sensitivity Cardiac Troponin T and Cognitive Function Over 12 Months After Stroke—Results of the DEMDAS Study
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.033439 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Regina von Rennenberg und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology (Klinik und Hochschulambulanz für Neurologie) Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berli…. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Stroke, Cognitive Dysfunction, Cerebral Small Vessel Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Subclinical myocardial injury in form of hs‐cTn (high‐sensitivity cardiac troponin) levels has been associated with cognitive impairment and imaging markers of cerebral small vessel disease (SVD) in population‐based and cardiovascular cohorts. Whether hs‐cTn is associated with domain‐specific cognitive decline and SVD burden in patients with stroke remains unknown. Methods and Results We analyzed patients with acute stroke without premorbid dementia from the prospective multicenter DEMDAS (DZNE [German Center for Neurodegenerative Disease]‐Mechanisms of Dementia after Stroke) study. Patients underwent neuropsychological testing 6 and 12 months after the index event. Test results were classified into 5 cognitive domains (language, memory, executive function, attention, and visuospatial function). SVD markers (lacunes, cerebral microbleeds, white matter hyperintensities, and enlarged perivascular spaces) were assessed on cranial magnetic resonance imaging to constitute a global SVD score. We examined the association between hs‐cTnT (hs‐cTn T levels) and cognitive domains as well as the global SVD score and individual SVD markers, respectively. Measurement of cognitive and SVD‐marker analyses were performed in 385 and 466 patients with available hs‐cTnT levels, respectively. In analyses adjusted for demographic characteristics, cardiovascular risk factors, and cognitive status at baseline, higher hs‐cTnT was negatively associated with the cognitive domains “attention” up to 12 months of follow‐up (beta‐coefficient, −0.273 [95% CI, −0.436 to −0.109]) and “executive function” after 12 months. Higher hs‐cTnT was associated with the global SVD score (adjusted odds ratio, 1.95 [95% CI, 1.27–3.00]) and the white matter hyperintensities and lacune subscores.
Conclusions
In patients with stroke, hs‐cTnT is associated with a higher burden of SVD markers and cognitive function in domains linked to vascular cognitive impairment. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01334749.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology (Klinik und Hochschulambulanz für Neurologie) Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.
- Center for Stroke Research Berlin (CSB) Charité-Universitätsmedizin Berlin Berlin Germany.
- German Center for Neurodegenerative Diseases (Deutsches Zentrum für Neurodegenerative Erkrankungen), partner site Berlin Berlin Germany.
- German Center for Cardiovascular Research (Deutsches Zentrum für Herz-Kreislaufforschung), partner site Berlin, Charité-Universitätsmedizin Berlin Berlin Germany.
- Berlin Institute of Health at Charité -Universitätsmedizin Berlin, BIH Biomedical Innovation Academy Berlin Germany.
- Department of Neurology, School of Medicine and Health Sciences Carl von Ossietzky University of Oldenburg Oldenburg Germany.
ORCID-Profile: Regina von Rennenberg, Christian H Nolte, Thomas G Liman, Simon Hellwig, Christoph Riegler, Jan F Scheitz, Marios K Georgakis, Rong Fang, Felix J Bode, Peter Hermann, Inga Zerr, Martin Dichgans, Matthias Endres
Zitieren
APA
von Rennenberg, R., Nolte, C. H., Liman, T. G., Hellwig, S., Riegler, C., Scheitz, J. F., Georgakis, M. K., Fang, R., Bode, F. J., Petzold, G. C., Hermann, P., Zerr, I., Goertler, M., Bernkopf, K., Wunderlich, S., Dichgans, M., Endres, M., & DEMDAS investigators * (2024). High‐Sensitivity Cardiac Troponin T and Cognitive Function Over 12 Months After Stroke—Results of the DEMDAS Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.033439
Vancouver
von Rennenberg R, Nolte CH, Liman TG, Hellwig S, Riegler C, Scheitz JF, et al. High‐Sensitivity Cardiac Troponin T and Cognitive Function Over 12 Months After Stroke—Results of the DEMDAS Study. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.033439
BibTeX
@article{vonRennenberg2024,
author = {von Rennenberg, Regina and Nolte, Christian H and Liman, Thomas G and Hellwig, Simon and Riegler, Christoph and Scheitz, Jan F and Georgakis, Marios K and Fang, Rong and Bode, Felix J and Petzold, Gabor C and Hermann, Peter and Zerr, Inga and Goertler, Michael and Bernkopf, Kathleen and Wunderlich, Silke and Dichgans, Martin and Endres, Matthias and DEMDAS investigators *, DEMDAS investigators *},
title = {High‐Sensitivity Cardiac Troponin T and Cognitive Function Over 12 Months After Stroke—Results of the DEMDAS Study},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.033439}
}
EUVIMED